This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: 3100 Central Expressway LLC, Attagene, Inc., Piksci Inc.. Active years: 2010-2024.
Company Filing History:
1 out of 1 
1 out of 3 
1 out of 1 Years Active: 2010-2024
Title: The Innovative Contributions of Sergei Romanov
Introduction
Sergei Romanov is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on fused triazolo-pyrimidine compounds. With a total of 3 patents to his name, Romanov's inventions have the potential to impact medical applications significantly.
Latest Patents
Among his latest patents, Romanov has developed compounds that serve as PIKfyve kinase inhibitors. These compounds, which include a compound and/or a pharmaceutically acceptable salt, are characterized by a specific formula that enhances their pharmaceutical utility. His work in this area demonstrates a commitment to advancing therapeutic options in the medical field.
Career Highlights
Throughout his career, Sergei Romanov has worked with various companies, including Attagene, Inc. and 3100 Central Expressway LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Romanov has collaborated with esteemed colleagues such as Robert J Greenhouse and Nikolai Sepetov. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of his work.
Conclusion
In summary, Sergei Romanov's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical applications.